Literature DB >> 10556155

NHLBI Workshop Summary. Pharmacological therapy for idiopathic pulmonary fibrosis. Past, present, and future.

R J Mason1, M I Schwarz, G W Hunninghake, R A Musson.   

Abstract

Entities:  

Mesh:

Year:  1999        PMID: 10556155     DOI: 10.1164/ajrccm.160.5.9903009

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  25 in total

Review 1.  Interferon gamma-1b therapy for cryptogenic fibrosing alveolitis.

Authors:  J Britton
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

Review 2.  Lung fibrosis.

Authors:  C Fonseca; D Abraham; C M Black
Journal:  Springer Semin Immunopathol       Date:  1999

Review 3.  Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches.

Authors:  Moisés Selman; Victor J Thannickal; Annie Pardo; David A Zisman; Fernando J Martinez; Joseph P Lynch
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 4.  Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy.

Authors:  Jeffrey C Horowitz; Victor J Thannickal
Journal:  Treat Respir Med       Date:  2006

5.  Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.

Authors:  Amarnath S Marudamuthu; Shwetha K Shetty; Yashodhar P Bhandary; Sophia Karandashova; Michael Thompson; Venkatachalem Sathish; Galina Florova; Taryn B Hogan; Christina M Pabelick; Y S Prakash; Yoshikazu Tsukasaki; Jian Fu; Mitsuo Ikebe; Steven Idell; Sreerama Shetty
Journal:  J Biol Chem       Date:  2015-02-03       Impact factor: 5.157

6.  Overexpression of the transcription factor GATA-3 enhances the development of pulmonary fibrosis.

Authors:  Toru Kimura; Yukio Ishii; Keigyou Yoh; Yuko Morishima; Takashi Iizuka; Takumi Kiwamoto; Yosuke Matsuno; Shinsuke Homma; Akihiro Nomura; Tohru Sakamoto; Satoru Takahashi; Kiyohisa Sekizawa
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

7.  Antiinflammation and Antioxidant Effects of Thalidomide on Pulmonary Fibrosis in Mice and Human Lung Fibroblasts.

Authors:  Xiaoying Dong; Xin Li; Minghui Li; Ming Chen; Qian Fan; Wei Wei
Journal:  Inflammation       Date:  2017-12       Impact factor: 4.092

8.  PG490-88, a derivative of triptolide, blocks bleomycin-induced lung fibrosis.

Authors:  G Krishna; K Liu; H Shigemitsu; M Gao; T A Raffin; G D Rosen
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

9.  Late treatment with imatinib mesylate ameliorates radiation-induced lung fibrosis in a mouse model.

Authors:  Minglun Li; Amir Abdollahi; Hermann-Josef Gröne; Kenneth E Lipson; Claus Belka; Peter E Huber
Journal:  Radiat Oncol       Date:  2009-12-21       Impact factor: 3.481

10.  Inhibitory effects of thalidomide on bleomycin-induced pulmonary fibrosis in rats via regulation of thioredoxin reductase and inflammations.

Authors:  Xiaoying Dong; Xin Li; Minghui Li; Ming Chen; Qian Fan; Wei Wei
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.